Self-assembled cyclodextrin aggregates and nanoparticles
- PMID: 19963052
- DOI: 10.1016/j.ijpharm.2009.11.035
Self-assembled cyclodextrin aggregates and nanoparticles
Abstract
Cyclodextrins (CDs) are widely used as enabling pharmaceutical excipients, mainly as solubilizing complexing agents. CDs are cyclic oligosaccharides with hydrophilic outer surface and a somewhat lipophilic central cavity. In aqueous solutions CDs are able to solubilize lipophilic drugs by taking up some lipophilic moiety of the drug molecule into the central cavity, i.e. through formation of hydrophilic inclusion complexes. Recently it has been observed that that other types of CD complexes, such as non-inclusion complexes, are also participating in the CD solubilization of poorly soluble drugs. However, in aqueous solutions CDs are also able self-assemble to form nanosized aggregates that can contribute to their solubilizing properties. At low CD concentrations (at about 1%, w/v) the fraction of CD molecules forming aggregates is insignificant but the aggregation increases rapidly with increasing CD concentration. Also, formation of CD complexes can increase the tendency of CDs to form aggregates and can lead to formation of micellar-type CD aggregates capable to solubilize poorly soluble compounds that do not readily form inclusion complexes. In this article formation of CD aggregates and CD nanoparticles is reviewed with emphasis on the physicochemical properties of self-assembled CDs and CD complexes.
2009 Elsevier B.V. All rights reserved.
Similar articles
-
Self-assembly of cyclodextrin complexes: aggregation of hydrocortisone/cyclodextrin complexes.Int J Pharm. 2011 Apr 4;407(1-2):174-83. doi: 10.1016/j.ijpharm.2011.01.011. Epub 2011 Jan 13. Int J Pharm. 2011. PMID: 21237259
-
Cyclodextrins.Int J Pharm. 2013 Aug 30;453(1):167-80. doi: 10.1016/j.ijpharm.2012.06.055. Epub 2012 Jul 5. Int J Pharm. 2013. PMID: 22771733 Review.
-
CDs as solubilizers: effects of excipients and competing drugs.Int J Pharm. 2009 Sep 8;379(1):32-40. doi: 10.1016/j.ijpharm.2009.06.005. Epub 2009 Jun 12. Int J Pharm. 2009. PMID: 19524652
-
Cyclodextrins in drug delivery.Expert Opin Drug Deliv. 2005 Mar;2(2):335-51. doi: 10.1517/17425247.2.1.335. Expert Opin Drug Deliv. 2005. PMID: 16296758 Review.
-
[Amphiphilic cyclodextrins and their applications. Preparation of nanoparticles based on amphiphilic cyclodextrins for biomedical applications].Ann Pharm Fr. 2010 Jan;68(1):12-26. doi: 10.1016/j.pharma.2009.12.002. Epub 2010 Feb 6. Ann Pharm Fr. 2010. PMID: 20176159 Review. French.
Cited by
-
Cytotoxicity of β-Cyclodextrins in Retinal Explants for Intravitreal Drug Formulations.Molecules. 2021 Mar 9;26(5):1492. doi: 10.3390/molecules26051492. Molecules. 2021. PMID: 33803405 Free PMC article.
-
Biomimetic and Biological Nanoarchitectonics.Int J Mol Sci. 2022 Mar 25;23(7):3577. doi: 10.3390/ijms23073577. Int J Mol Sci. 2022. PMID: 35408937 Free PMC article. Review.
-
Physicochemical properties of β-cyclodextrin solutions and precipitates prepared from injectable vehicles.Asian J Pharm Sci. 2018 Sep;13(5):438-449. doi: 10.1016/j.ajps.2018.02.002. Epub 2018 Mar 16. Asian J Pharm Sci. 2018. PMID: 32104418 Free PMC article.
-
Molecular mechanism of cyclodextrin mediated cholesterol extraction.PLoS Comput Biol. 2011 Mar;7(3):e1002020. doi: 10.1371/journal.pcbi.1002020. Epub 2011 Mar 24. PLoS Comput Biol. 2011. PMID: 21455285 Free PMC article.
-
Novel 1-indanone Thiosemicarbazone Antiviral Candidates: Aqueous Solubilization and Physical Stabilization by Means of Cyclodextrins.Pharm Res. 2012 Mar;29(3):739-55. doi: 10.1007/s11095-011-0599-y. Epub 2011 Oct 6. Pharm Res. 2012. PMID: 21975565
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources